NCT03658512 Tübinger Diabetes Mellitus Database (TUEDID)
| NCT ID | NCT03658512 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Tuebingen |
| Condition | Diabetes Mellitus |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2018-08-13 |
| Primary Completion | 2028-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2018-08-13 with a primary completion date of 2028-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Diabetes mellitus is a widespread disease with increasing prevalence worldwide. Patients with diabetes can develop multiple late complications such as neuropathy, retinopathy, nephropathy and cardiovascular comorbidities. So far, there are no reliable predictive tools or markers to estimate if, when and to what extent a patient with diabetes develops late complications. For the patients quality of life and for health economic reasons an improved risk assessment would be desirable. The prospective TUEDID study will characterize diabetic patients to look out for parameters the predict progression of diabetes and its complications.
Eligibility Criteria
Inclusion Criteria: * \>18 years Exclusion Criteria: * no written informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03658512 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Diabetes Mellitus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03658512 currently recruiting?
Yes, NCT03658512 is actively recruiting participants. Contact the research team at andreas.fritsche@med.uni-tuebingen.de for enrollment information.
Where is the NCT03658512 trial being conducted?
This trial is being conducted at Tübingen, Germany.
Who is sponsoring the NCT03658512 clinical trial?
NCT03658512 is sponsored by University Hospital Tuebingen. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.